Loading
Life sciences · Journal article
Gut Microbes · August 25, 2026
A consensus or society position rather than new primary data.
This is a narrative review synthesizing evidence that glycosylation regulates multiple steps in gut-brain communication, including intestinal barrier function, microbial metabolism, immune signaling, and neural responses. The authors distinguish direct mechanistic findings from associative observations and propose glycosylation-targeted interventions as emerging therapeutic avenues, but do not report new empirical data or quantify clinical effects.
Narrative review article. Conceptual framework integrating evidence from studies of gut microbiota, intestinal epithelial barrier, immune system, and central nervous system in health and disease; no specific patient population studied. International; authors affiliated with institutions in China, Japan, and international collaborations.
Glycosylation influences intestinal barrier function through highly O-glycosylated mucins secreted by goblet cells, forming a physical barrier separating luminal microbes from epithelium Glycosylated structures (mucin O-glycans, human milk oligosaccharides) serve as nutrient sources and adhesion substrates for gut microbes, shaping intestinal ecosystem composition and function Gut microorganisms express glycosidases to degrade host glycans, generating signaling metabolites (short-chain fatty acids, secondary bile acids) that may influence brain function through immune, endocrine, and vagal pathways
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and researchers should recognize glycosylation as a regulatory mechanism linking gut microbiota function to immune and neural signaling. This framework suggests that glycosylation-targeted nutritional and microbiota-based interventions warrant investigation for gastrointestinal, metabolic, and neuropsychiatric disorders, though specific clinical recommendations await empirical trials.
A comprehensive narrative review synthesizing mechanistic and associative evidence on glycosylation's role in gut-brain communication, identifying regulatory pathways and therapeutic opportunities but not reporting original empirical findings or clinical outcomes.
As stated by the source record.
Clinicians and researchers should recognize glycosylation as a regulatory mechanism linking gut microbiota function to immune and neural signaling. This framework suggests that glycosylation-targeted nutritional and microbiota-based interventions warrant investigation for gastrointestinal, metabolic, and neuropsychiatric disorders, though specific clinical recommendations await empirical trials.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
The gut-brain axis is a complex bidirectional communication network linking the gastrointestinal tract and the central nervous system. Its dysregulation is closely associated with a wide range of gastrointestinal, metabolic, and neuropsychiatric disorders. Glycosylation, one of the most prevalent and structurally diverse post-translational modifications of proteins and lipids, is increasingly recognized as a regulator of multiple processes within the gut-brain axis. In this review, we summarize evidence that glycosylation influences several steps of gut-brain communication, including intestinal barrier function, microbial glycan metabolism, immune signaling, enteric and vagal pathways, blood-brain barrier integrity, and neural responses. We distinguish direct mechanistic findings from associative observations and discuss the more limited evidence for brain-to-gut regulation of intestinal glycosylation. In addition, we discuss the potential of glycosylation-targeted nutritional and microbiota-based interventions and highlight emerging opportunities to integrate glycomics with other omics approaches to dissect the complex regulatory networks underlying the gut-brain axis. In conclusion, elucidating how glycosylation shapes signaling along the gut-brain axis may open new avenues for understanding disease pathogenesis and for developing targeted therapeutic strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.